Citations

Clear

585 citation(s) found for "Tran, Ha".

Preoperative Orbital Compliance as a Predictor for Outcomes of Fat Decompression in Thyroid Eye Disease
Shteyman, Amy , Gregerson, Celestine, Stevens, Shanlee, Tran, Ann Q. , Coombs, Allison, Tooley, Andrea A. , Kazim, Michael, Coombs, Allison V., Kazim, Michael

Mayo Clinic

Ophthalmic Plastic & Reconstructive Surgery | May 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/iop.0000000000003231 | PMID 42113591 Get It

Purpose: To determine the clinical utility of the assessment of preoperative orbital compliance in predicting the amount of postoperative proptosis reduction in patients with stable-phase thyroid eye disease who undergo orbital fat decompression surgery. Methods: A retrospective chart review was conducted of stable-phase thyroid eye disease patients who underwent orbital fat decompression by a single surgeon. Orbital compliance was measured preoperatively as axial globe displacement (in millimeters) using a Hertel exophthalmometer. Displacement ≥2.5 mm was classified as high compliance and <2.5 mm as low compliance. Radiographic thyroid eye disease type, preoperative proptosis, and intraoperative fat volume removed were recorded. Linear regression analysis determined whether orbital compliance independently predicted postoperative proptosis reduction. Levene’s test assessed variability between groups. Results: Forty-six orbits from 24 patients were included, 15 orbits with low compliance and 31 with high orbital compliance. Patients with high orbital compliance had a mean postoperative proptosis reduction of 3.19 mm (range 0.5–6.0 mm) while patients with low orbital compliance had a mean proptosis reduction of 2.67 mm (range 2.0–3.5 mm). On average, higher preoperative orbital compliance led to 0.959 mm greater proptosis reduction compared with low orbital compliance, when accounting for radiographic thyroid eye disease type and volume of fat removed intraoperatively ( p = 0.048). Variability in proptosis reduction was higher among the high orbital compliance group ( p = 0.00085). Conclusions: Higher preoperative orbital compliance results in greater proptosis reduction. However, patients with high orbital compliance have greater variability in proptosis reduction, suggesting that surgical outcomes are less predictable among these patients.
OLIG2-STAT5 cooperation supports glioma stem cell maintenance and proliferation in glioblastoma
Miller, Aunay , McNamara, James, Blomquist, Mylan, Nascari, David, Flick, Matthew, Saladin, Sidney, Tuncali, Serdar, Sereduk, Christopher, Orndorf, Keely, Ensign, Shannon P Fortin, Loftus, Joseph C. , Mehta, Shwetal, Ensign, Shannon P. Fortin , Blomquist, Mylan R, Tran, Nhan L , Mehta, Shwetal , Ensign, Shannon P. Fortin , McNamara, James, Nascari, David , Tuncali, Serdar, Sereduk, Chris , Orndorff, Keely, Tran, Nhan L.

Mayo Clinic

Neuro-Oncology Advances | May 9, 2026 | Volume: 8 | Issue: 1 | Pages: No page available

10.1093/noajnl/vdag127 | PMID 42222434 Get It

Abstract Background Glioblastoma (GBM) is driven, in part, by glioma stem cells (GSCs), which sustain therapeutic resistance and recurrence. OLIG2 is a key regulator of GSC programs but the signaling pathways that cooperate with Oligodendrocyte transcription factor 2 (OLIG2) to maintain GSC states remain incompletely defined. Although Signal transducer and activator of transcription (STAT) signaling has been implicated in GSC biology, work to date has focused primarily on STAT3, and the contribution of STAT5 remains poorly defined. Here, we investigated whether STAT5B functionally cooperates with OLIG2 in sustaining GSC phenotypes. Methods Transcriptomic analyses, proximity ligation assays and biochemical studies were utilized to define OLIG2-STAT5B interactions in patient-derived GSCs. Functional consequences of OLIG2, STAT5B, BIRC5, and NUSAP1 suppression were assessed using small interfering RNA/short hairpin RNA-knockdown, stemness, and migration assays in EGFRvIII-expressing GSCs. In vivo tumor growth studies were performed using orthotopic xenograft models. Results OLIG2 and STAT5B expression were positively correlated in GBM datasets and patient-derived models. OLIG2 physically associated with STAT5B in EGFRvIII-expressing GSCs, and loss of OLIG2 reduced STAT5 activation, supporting a functional link between these factors. OLIG2 or STAT5B suppression induced convergent transcriptional changes, including downregulation of genes associated with GSC maintenance and proliferation, notably stemness regulators BIRC5 and NUSAP1. Silencing BIRC5 or NUSAP1 impaired GSC self-renewal and migration. In orthotopic models, STAT5B knockdown prolonged survival and phenocopied OLIG2 suppression and stemness loss. Conclusions These findings identify STAT5B as a functional partner of OLIG2 in GBM and define anOLIG2-STAT5B transcriptional axis that sustains GSC maintenance and malignant behavior. Targeting this axis may represent a therapeutic strategy to disrupt treatment-refractory glioma cell states.
Optimal Timing of Coronary Artery Bypass Grafting in Patients with NSTEMI – A National Study from The United States
Tran, Viet Nghi, Pham, Hoang Nhat, Ibrahim, Ramzi, Truong, Hong Hieu, Abdelnabi, Mahmoud, Dhindsa, Amreen , Le, Pham Thao Vy, Nguyen, Doan Ngoc Chau, Jamal, Aisha, Tran, Phillip, Nguyen, Thach, Chahal, Anwar, Lee, Kwan S, Arsanjani, Reza, Singh, Amitoj, Tran, Viet Nghi, Pham, Hoang Nhat , Ibrahim, Ramzi , Abdelnabi, Mahmoud , Tran, Phillip , Chahal, C. Anwar A. , Arsanjani, Reza , Singh, Amitoj

Mayo Clinic

Marshall Journal of Medicine | May 1, 2026 | Volume: 12 | Issue: 2 | Pages: No page available

10.33470/2379-9536.1509 Get It

Background: The timing of coronary artery bypass grafting (CABG) in patients with non-ST-elevation myocardial infarction (NSTEMI) may critically impact clinical outcomes, yet the ideal surgical window remains unclear. We aimed to evaluate the association between time-to-CABG and in-hospital outcomes among NSTEMI admissions undergoing CABG. Methods: This retrospective cohort study utilized the US National Inpatient Sample database from 2017 to 2021 to evaluate the association between time-to-CABG and key in-hospital outcomes, including mortality, cardiac arrest, cardiogenic shock, ischemic stroke, acute kidney injury, and blood transfusion rates, while assessing length of stay (LOS) and hospital charges exclusively among survivors. Adult admissions with principal diagnosis of NSTEMI who underwent CABG without prior interhospital transfer were grouped by the calendar day of CABG from admission (0, 1, 2, 3, 4, 5, 6, and ≥7). Multivariate regression models were used to assess the outcomes across these eight groups. Results: Of 142,200 included admissions, same-day CABG (hospital day 0) was associated with the highest rates of in-hospital mortality, cardiac arrest, cardiogenic shock, and ischemic stroke. The adjusted odds of mortality, cardiac arrest, and cardiogenic shock were lower among admissions undergoing CABG between days 2 and 5. Likewise, the adjusted odds of ischemic stroke were lowest when CABG occurred on days 2 to 4. The odds of AKI increased when CABG was delayed beyond day 6, whereas blood transfusion rates showed no statistically significant association with time-to-CABG. Among survivors, LOS and hospital charges progressively increased with delayed CABGs. Conclusions: Among NSTEMI admissions undergoing CABG, CABG performed on hospital days 2 to 4 was associated with lower adjusted odds of several adverse in-hospital outcomes compared with same-day CABG. Further prospective studies are needed to validate these results and guide clinical decision-making.
Vitamin D deficiency and systemic inflammation in hidradenitis suppurativa: clinical correlates in a retrospective cohort
Shrestha, Raslina , Van, Duc L., Tran, Hue T T, Ma, Jun, Alavi, Afsaneh, Davis, Mark, Wetter, David A, Lu, Kurt Q. , Nguyen, Giang H, Nguyen, Giang Huong , Tran, Hue T, Nguyen, Giang H , Tran, Hue T.T. , Alavi, Afsáneh , Davis, Mark D.P. , Wetter, David A.

Mayo Clinic

British Journal of Dermatology | April 30, 2026 | Volume: 195 | Issue: 2 | Pages: 339-341

10.1093/bjd/ljag157 | PMID 42056003 Get It

Vitamin D deficiency is frequently reported in hidradenitis suppurativa (HS), but its clinical significance remains unclear. In a retrospective cohort of 503 patients, deficiency was common and associated with demographic and metabolic factors but not with treatment-defined severity. Vitamin D deficiency was independently associated with elevated C-reactive protein, suggesting a link with systemic inflammation.
Pan-cancer virtual spatial transcriptomics from routine histology with Phoenix
Tran, Manuel , Gindra, Rushin H. , Putze, Philipp , Senbai, 康森柏 Kang, Kos, Tina, Wang, C, Guo, Ruifeng (Ray), Boxberg, Melanie , Lindner, Lars H., Bergmayr, Linda , Jurmeister, Philipp, Klauschen, F, Homicsko, Krisztian, Gottardo, Raphael, Eckstein, Markus, Matek, Christian , Gindra, Rushin H. , Palla, Giovanni , Šket, Tina , Falcomatà, Chiara , Guo, R., Berclaz, Luc M. , Lindner, Lars Hartwin , Knösel, Thomas , Homicskó, Krisztián , Gottardo, Raphaël , Eckstein, Markus , Möck, Andreas , Theis, Fabian Joachim , Saur, Dieter , Peng, Tingying

Mayo Clinic

No container title available | April 30, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.04.25.720812 Get It

Abstract Spatial transcriptomics links gene expression to tissue architecture, providing a mechanistic view of cellular organization. Yet existing datasets cover few donors and miss the complexity of human disease. Experimental costs remain prohibitive, and large-scale profiling is impractically slow for population-level studies. Accurate computational methods are urgently needed. Predicting gene expression from standard histology, however, remains an open problem, as current approaches transfer poorly to unseen cohorts and diseases. Here, we present Phoenix, a (latent) flow matching generative model that infers pan-cancer spatially resolved single-cell gene expression with high accuracy. Phoenix analyzes treatment response in silico: Applied to 763 head and neck cancer patients, it identified three new spatial biomarkers that we validated across two cancers (breast cancer, n = 84; ovarian cancer, n = 157) and treatment regimens (platinum, trastuzumab). Phoenix generalizes beyond carcinomas: In a large sarcoma cohort (802 tissue microarray cores), it accurately predicted cell-type-specific signatures in held-out samples and captured chemotherapy-induced immune remodeling. Phoenix also extends across species: In a mouse model, it accurately predicted the expression of pancreatic cancer lineage markers and the mutant mKras^G12D allele in silico. In total, we evaluated Phoenix on over 10,000 patients. Our results establish virtual spatial transcriptomics as a scalable framework for studying tissue organization, therapeutic response, and disease mechanisms.
Discovery of Structurally Distinct Covalent KRAS G12C Inhibitor Scaffolds Through Large-Scale In Silico Screening and Experimental Validation
Weiss, Glen J. , Loftus, Joseph C. , Mallery, David, Tran, Nhan L. , Weiss, Glen J , Tran, Nhan L

Mayo Clinic

Cancers | April 27, 2026 | Volume: 18 | Issue: 9 | Pages: 1367

10.3390/cancers18091367 | PMID 42122163 Get It

Background/Objectives: KRAS G12C mutations define a clinically actionable subset of solid tumors, particularly non–small cell lung cancer. Clinical responses to approved covalent inhibitors remain limited by intrinsic and acquired resistance, highlighting the need for structurally distinct inhibitor scaffolds to expand therapeutic options. The objective of this study was to identify novel covalent binders targeting the KRAS G12C switch-II pocket through large-scale in silico screening and experimental validation. Methods: More than 1.9 million small molecules from diverse commercial libraries were screened using covalent docking, followed by multi-stage refinement incorporating molecular dynamics simulations, MM/GBSA free-energy estimation, and cancer-focused QSAR modeling. Results: This integrated workflow yielded 50 prioritized compounds spanning several chemically distinct scaffold classes. These candidates displayed favorable predicted binding energetics, stable ligand-protein interactions over extended simulation timescales, and low structural similarity to clinically approved KRAS G12C inhibitors sotorasib and adagrasib. Benchmarking against these clinical agents, using identical computational parameters, yielded comparable predicted binding energies for several candidate molecules. In cellular NanoBRET target-engagement assays, selected scaffolds, including K788-7251 and AN-989/14669131, exhibited sub-micromolar engagement of KRAS G12C with minimal endothelial cytotoxicity. Conclusions: Collectively, these findings identify structurally distinct, KRAS G12C inhibitor chemotypes and provide tractable starting points for the development of next-generation targeted therapies.
Clinical-grade cryopreservation unlocks transplant-ready human pancreatic and stem cell–derived islets for diabetes therapy
Guo, Zongqi, Khashim, Zenith , Knofczynski, Kyle, Tobolt, Diane, Shivakumar, Sharath Belame, Rangarajan, Parthasarathy , Herman, Adam , Abdulla, Muhamad, Tran, Anna , Fisher, Benjamin , Salomon, Tiana, Lewis-Brinkman, Sean , Steinhoff, Magie, Balamurugan, Appakalai N. , Hering, Bernhard J. , Bischof, John, Finger, Erik B. , Rao, Joseph Sushil , Knofczynski, Kyle R , Fisher, Benjamin J., Etheridge, Michael L. , Ramachandran, Sabarinathan , Peterson, Quinn P. , Bischof, John C , Finger, Erik B.

Mayo Clinic

No container title available | April 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.64898/2026.04.25.720819 | PMID 42094508 Get It

ABSTRACT Pancreatic islet transplantation can restore endogenous insulin production and offers a potential cure for diabetes, but its clinical impact has been limited by the inability to preserve large numbers of functional islets for timely use. Cryopreservation could provide an on-demand supply, yet conventional methods cause ice formation, cell injury, and loss of insulin secretion. We developed CryoMesh, a vitrification platform that combines a low-toxicity cryoprotectant with a thermally conductive, biocompatible mesh to enable ultra-rapid cooling and rewarming for ice-free cryopreservation. This approach supports long-term, clinical-scale preservation of both human pancreatic and stem cell–derived islets while maintaining viability, architecture, mitochondrial integrity, and glucose-responsive insulin secretion. Human islets preserved for up to one year restored normoglycemia in diabetic mice, with complete recovery of function and no increase in immunogenicity or loss of potency. The combination of high viability, recovery, and functional preservation at clinical scale has not been achieved previously. By decoupling islet isolation and manufacture from transplantation, CryoMesh enables extended quality, potency, and safety testing, cost-effective batch production, and global banking and distribution. These capabilities remove a major barrier to curative cell therapy for diabetes and establish a generalizable strategy for preserving complex multicellular therapeutics. One Sentence Summary A clinical scale vitrification platform enables long-term banking of human pancreatic and stem cell–derived islets for transplantation.
Designing a Collaborative Immersive Visualization System for Radiation Treatment Planning Teams
Tran, Kiet , Broske, Matthias , Herman, Michael G., Interrante, Victoria , Rosenberg, Evan Suma , Mundy, Daniel, Keefe, Daniel F. , Mundy, Daniel W.

Mayo Clinic

IEEE Transactions on Visualization and Computer Graphics | April 23, 2026 | Volume: 32 | Issue: 7 | Pages: 6712-6725

10.1109/tvcg.2026.3686821 | PMID 42024930 Get It

Educating Anesthesiology Residents and Their Support Persons to Improve Understanding and Increase Wellness: A Multisite Study
Martinelli, Susan M. , Tran, Thanh N. , Canter, Courtney , Hu, Di , Isaak, Robert S., Mulaikal, Teresa A., Ladlie, Beth L., Jain, Ankit , Willie, Chelsea, Stahl, David, Carter, Tekuila R., Zisblatt, Lara , Hoefnagel, A. L. , Marshall, Julie , Collins, Stephen, Martin, TD, Stahl, David L. , Ladlie, Beth, Carter, Tekuila R , Marshall, Julie M , Isaak, Robert S. , Afroze, Farzana, Jain, Ankit, Keneally, Ryan J. , Chen, Fengqian

Mayo Clinic

Anesthesia & Analgesia | April 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1213/ane.0000000000008030 | PMID 41962000 Get It

BACKGROUND: Burnout remains prevalent among anesthesiology residents. Contributing workplace factors include limited control over scheduling, unpredictable hours, critical patient care needs, and other residency challenges. The Family Anesthesia Experience (FAX) is a program designed to educate residents and their support persons on wellness and residency demands. The focus of this multisite study was to evaluate the impact of FAX on first year clinical anesthesiology (CA1, ie, PGY2s) residents’ wellness. METHODS: This was a prospective evaluation study involving 15 US anesthesiology residency programs, 13 of which completed FAX. CA1 wellness was evaluated through surveys assessing perceived stress as the primary outcome, with exploratory outcomes including burnout, depression, psychological wellness, and social support. Additionally, changes in support persons’ understanding and knowledge of residency demands were tracked over time. The study included a historical control group of 302 CA1s (2019-2021) who did not participate in FAX, and an intervention group of 88 CA1s that participated in FAX (2021-2022). Statistical analyses compared changes in metrics between groups using linear mixed models and generalized linear models. RESULTS: Significant reductions in perceived stress were observed in the intervention group at 6 months post-FAX (mean change = –2.14, 95% CI, –3.95 to –0.34; P = .021, effect size = 0.58) relative to the control group, but there was no sustained difference at 12 months. Compared to the control support persons, intervention support persons reported increased understanding of residency demands, with significant improvements at 6 (mean change = 2.80, 95% CI, 1.12–4.48; P = .001, effect size = 0.77) and 12 (mean change = 2.59, 95% CI, 0.12–5.05; P = .039, effect size = 0.71) months. Improvement in support persons’ understanding did not predict changes in CA1 wellness outcomes. First generation physician residents reported lower family support at baseline but showed significant improvements in family support at 6 months (mean change = 3.05 points; 95% CI, 0.25–5.84; P = .033; effect size = 1.23) compared to their non first generation peers. CONCLUSIONS: FAX participation was associated with reduced perceived stress in residents up to 6 months post-intervention. First generation physicians experienced greater improvements in perceived family support compared to their non first generation peers. Our findings suggest that resident wellness may be enhanced by engaging both residents and their support persons in an educational wellness program that outlines the professional expectations and demands of anesthesiology residency training.